BNP Paribas Financial Markets’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4 | Sell |
1
-1
| -50% | -$7 | ﹤0.01% | 5881 |
|
|
2026
Q1 | $21 | Hold |
2
| – | – | ﹤0.01% | 5751 |
|
|
2025
Q4 | $23 | Sell |
2
-22
| -92% | -$340 | ﹤0.01% | 5665 |
|
|
2025
Q3 | $578 | Sell |
24
-46
| -66% | -$766 | ﹤0.01% | 5300 |
|
|
2025
Q2 | $1.15K | Sell |
70
-4,230
| -98% | -$73K | ﹤0.01% | 5132 |
|
|
2025
Q1 | $78.3K | Buy |
4,300
+109
| +3% | +$3.11K | ﹤0.01% | 4129 |
|
|
2024
Q4 | $155K | Buy |
4,191
+2,216
| +112% | +$84.8K | ﹤0.01% | 3996 |
|
|
2024
Q3 | $63.2K | Buy |
1,975
+480
| +32% | +$26.6K | ﹤0.01% | 3567 |
|
|
2024
Q2 | $123K | Sell |
1,495
-627
| -30% | -$67.8K | ﹤0.01% | 3242 |
|
|
2024
Q1 | $307K | Sell |
2,122
-933
| -31% | -$78.8K | ﹤0.01% | 3100 |
|
|
2023
Q4 | $281K | Buy |
3,055
+425
| +16% | +$43.2K | ﹤0.01% | 3091 |
|
|
2023
Q3 | $434K | Buy |
2,630
+1,744
| +197% | +$227K | ﹤0.01% | 2795 |
|
|
2023
Q2 | $56K | Sell |
886
-1,334
| -60% | -$80.8K | ﹤0.01% | 3435 |
|
|
2023
Q1 | $75.4K | Sell |
2,220
-2,046
| -48% | -$107K | ﹤0.01% | 3371 |
|
|
2022
Q4 | $247K | Buy |
4,266
+2,659
| +165% | +$164K | ﹤0.01% | 2924 |
|
|
2022
Q3 | $151K | Buy |
1,607
+623
| +63% | +$88.7K | ﹤0.01% | 3609 |
|
|
2022
Q2 | $219K | Buy |
984
+703
| +250% | +$235K | ﹤0.01% | 3042 |
|
|
2022
Q1 | $155K | Sell |
281
-407
| -59% | -$246K | ﹤0.01% | 3213 |
|
|
2021
Q4 | $455K | Buy |
688
+84
| +14% | +$64.2K | ﹤0.01% | 3049 |
|
|
2021
Q3 | $507K | Buy |
604
+487
| +416% | +$494K | ﹤0.01% | 2739 |
|
|
2021
Q2 | $149K | Sell |
117
-268
| -70% | -$302K | ﹤0.01% | 2930 |
|
|
2021
Q1 | $423K | Sell |
385
-107
| -22% | -$141K | ﹤0.01% | 2657 |
|
|
2020
Q4 | $703K | Sell |
492
-127
| -21% | -$135K | ﹤0.01% | 2265 |
|
|
2020
Q3 | $437K | Buy |
619
+512
| +479% | +$372K | ﹤0.01% | 2294 |
|
|
2020
Q2 | $75K | Sell |
107
-337
| -76% | -$195K | ﹤0.01% | 2878 |
|
|
2020
Q1 | $155K | Sell |
444
-15,691
| -97% | -$11.1M | ﹤0.01% | 2986 |
|
|
2019
Q4 | $10.1M | Buy |
16,135
+15,943
| +8,304% | +$7.8M | 0.02% | 833 |
|
|
2019
Q3 | $64.3K | Buy |
192
+125
| +187% | +$40.1K | ﹤0.01% | 3347 |
|
|
2019
Q2 | $17.5K | Sell |
67
-60
| -47% | -$12K | ﹤0.01% | 3946 |
|
|
2019
Q1 | $21K | Buy |
127
+118
| +1,311% | +$19.2K | ﹤0.01% | 3895 |
|
|
2018
Q4 | $975 | Sell |
9
-9
| -50% | -$1.52K | ﹤0.01% | 3925 |
|
|
2018
Q3 | $4.48K | Sell |
18
-4
| -18% | -$861 | ﹤0.01% | 4105 |
|
|
2018
Q2 | $4.81K | Sell |
22
-72
| -77% | -$13.3K | ﹤0.01% | 4112 |
|
|
2018
Q1 | $13.7K | Buy |
+94
| New | +$15.9K | ﹤0.01% | 3982 |
|
Other funds holding CDLX
VCM
KGAMU
WPM
VFT
KWM
BNP Paribas Financial Markets's CDLX Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Cardlytics (CDLX) stake by 50% in Q2 2026, selling an estimated $7 and leaving 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5881.
BNP Paribas Financial Markets first reported a position in CDLX in Q1 2018 and has held it in 34 quarters since. The position peaked at $10.1M in Q4 2019. 26 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- BNP Paribas Financial Markets held 1 share of Cardlytics worth $4 as of Q2 2026.
- BNP Paribas Financial Markets sold 1 Cardlytics share in Q2 2026, an estimated $7.
- Cardlytics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5881 holding.
- BNP Paribas Financial Markets first reported a position in Cardlytics in Q1 2018 and has held it in 34 quarters since.
- BNP Paribas Financial Markets's Cardlytics position peaked at $10.1M in Q4 2019.
- 26 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.